What is Ips Research?
Founded in 1996 by Dr. Louise Thurman, Ips Research is a prominent leader in innovative research practices across the United States. The company is dedicated to 'Discovering Better,' focusing on integrity, people, and service. By partnering with patients and pharmaceutical clients, Ips Research aims to achieve superior clinical trial performance through enhanced data collection and clinical practice, thereby serving a greater global need while making a tangible impact at the individual level.
How much funding has Ips Research raised?
Ips Research has raised a total of $400K across 2 funding rounds:
Debt
$150K
Debt
$250K
Debt (2020): $150K with participation from PPP
Debt (2021): $250K led by PPP
What's next for Ips Research?
The company's recent major strategic investment, following substantial debt financing rounds, indicates a transition towards scaling operations and potentially expanding its service offerings or geographical reach. This late-stage funding context suggests Ips Research is poised for significant growth, likely focusing on solidifying its market leadership and further innovating its research methodologies. Future developments may include strategic partnerships or acquisitions to accelerate its mission.
See full Ips Research company page